Mirae Asset Global Etfs Holdings Ltd. Revolution Medicines, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 76,950 shares of RVMD stock, worth $4.65 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,950Holding current value
$4.65 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
245Shares Held
160MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$869 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$826 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$810 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$590 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$457 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.3B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...